Third-Party Reviews Should Be Used Only If Expertise Is Lacking – MDMA
This article was originally published in The Gray Sheet
Executive Summary
The Medical Device Manufacturers Association is seeking to toughen FDA device reform legislation to prevent outside expert reviews of PMAs from occurring unless the agency lacks resources to conduct the reviews in-house
You may also be interested in...
Integra Scarring Approval Backed By Expert In Panel “Homework Assignment”
Integra LifeSciences' expanded dermal regeneration template approval for repair of scar contractures shows that FDA is open to receiving input from outside experts when conducting a PMA review
Integra Scarring Approval Backed By Expert In Panel “Homework Assignment”
Integra LifeSciences' expanded dermal regeneration template approval for repair of scar contractures shows that FDA is open to receiving input from outside experts when conducting a PMA review
Device User Fees On The Table For PDUFA III: Senate Cmte. In Discussions
Senate Health, Education, Labor & Pensions (HELP) Committee staffers are actively considering device user fee language for inclusion in the Prescription Drug User Fee Act reauthorization this year